A citation-based method for searching scientific literature

Riccardo Inchingolo, Francesco Varone, Giacomo Sgalla, Luca Richeldi. Expert Rev Respir Med 2019
Times Cited: 11







List of co-cited articles
34 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
36

Idiopathic pulmonary fibrosis.
Luca Richeldi, Harold R Collard, Mark G Jones. Lancet 2017
427
27


An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
27

Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs?
Moisés Selman, Annie Pardo, Naftali Kaminski. PLoS Med 2008
234
18

Metformin reverses established lung fibrosis in a bleomycin model.
Sunad Rangarajan, Nathaniel B Bone, Anna A Zmijewska, Shaoning Jiang, Dae Won Park, Karen Bernard, Morgan L Locy, Saranya Ravi, Jessy Deshane, Roslyn B Mannon,[...]. Nat Med 2018
163
18

Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signalling.
Patrick Hofmann, Janina Sommer, Kosta Theodorou, Luisa Kirchhof, Ariane Fischer, Yuhuang Li, Ljubica Perisic, Ulf Hedin, Lars Maegdefessel, Stefanie Dimmeler,[...]. Cardiovasc Res 2019
49
18

Epithelial-mesenchymal interactions in pulmonary fibrosis.
Harold A Chapman. Annu Rev Physiol 2011
260
18

Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.
H Liang, Y Gu, T Li, Y Zhang, L Huangfu, M Hu, D Zhao, Y Chen, S Liu, Y Dong,[...]. Cell Death Dis 2014
70
18

Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis.
Zhongwei Cao, Raphael Lis, Michael Ginsberg, Deebly Chavez, Koji Shido, Sina Y Rabbany, Guo-Hua Fong, Thomas P Sakmar, Shahin Rafii, Bi-Sen Ding. Nat Med 2016
113
18

Matrix Remodeling in Pulmonary Fibrosis and Emphysema.
Tejaswini Kulkarni, Philip O'Reilly, Veena B Antony, Amit Gaggar, Victor J Thannickal. Am J Respir Cell Mol Biol 2016
52
18

Activated alveolar epithelial cells initiate fibrosis through autocrine and paracrine secretion of connective tissue growth factor.
Jibing Yang, Miranda Velikoff, Ernesto Canalis, Jeffrey C Horowitz, Kevin K Kim. Am J Physiol Lung Cell Mol Physiol 2014
50
18

Activated alveolar epithelial cells initiate fibrosis through secretion of mesenchymal proteins.
Jibing Yang, Sarah E Wheeler, Miranda Velikoff, Kathryn R Kleaveland, Michael J LaFemina, James A Frank, Harold A Chapman, Paul J Christensen, Kevin K Kim. Am J Pathol 2013
54
18


Idiopathic pulmonary fibrosis: pathogenesis and management.
Giacomo Sgalla, Bruno Iovene, Mariarosaria Calvello, Margherita Ori, Francesco Varone, Luca Richeldi. Respir Res 2018
119
18

A common MUC5B promoter polymorphism and pulmonary fibrosis.
Max A Seibold, Anastasia L Wise, Marcy C Speer, Mark P Steele, Kevin K Brown, James E Loyd, Tasha E Fingerlin, Weiming Zhang, Gunnar Gudmundsson, Steve D Groshong,[...]. N Engl J Med 2011
587
18

Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.
Tracy J Doyle, Avignat S Patel, Hiroto Hatabu, Mizuki Nishino, Guodong Wu, Juan C Osorio, Maria F Golzarri, Andres Traslosheros, Sarah G Chu, Michelle L Frits,[...]. Am J Respir Crit Care Med 2015
72
18

Progressive preclinical interstitial lung disease in rheumatoid arthritis.
Bernadette R Gochuico, Nilo A Avila, Catherine K Chow, Levi J Novero, Hai-Ping Wu, Ping Ren, Sandra D MacDonald, William D Travis, Mario P Stylianou, Ivan O Rosas. Arch Intern Med 2008
201
18

Biomarkers in idiopathic pulmonary fibrosis.
F Drakopanagiotakis, Lukasz Wujak, Malgorzata Wygrecka, P Markart. Matrix Biol 2018
37
18

Idiopathic pulmonary fibrosis.
Fernando J Martinez, Harold R Collard, Annie Pardo, Ganesh Raghu, Luca Richeldi, Moises Selman, Jeffrey J Swigris, Hiroyuki Taniguchi, Athol U Wells. Nat Rev Dis Primers 2017
274
18

Blood Biomarkers in Idiopathic Pulmonary Fibrosis.
Julien Guiot, Catherine Moermans, Monique Henket, Jean-Louis Corhay, Renaud Louis. Lung 2017
55
18

A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.
Antje Prasse, Dmitri V Pechkovsky, Galen B Toews, Wolfgang Jungraithmayr, Florian Kollert, Torsten Goldmann, Ekkehard Vollmer, Joachim Müller-Quernheim, Gernot Zissel. Am J Respir Crit Care Med 2006
282
18

Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression.
Jason W Chien, Thomas J Richards, Kevin F Gibson, Yingze Zhang, Kathleen O Lindell, Lixin Shao, Susan K Lyman, Joanne I Adamkewicz, Victoria Smith, Naftali Kaminski,[...]. Eur Respir J 2014
82
18

Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.
Thomas J Richards, Naftali Kaminski, Fred Baribaud, Susan Flavin, Carrie Brodmerkel, Daniel Horowitz, Katherine Li, Jiin Choi, Louis J Vuga, Kathleen O Lindell,[...]. Am J Respir Crit Care Med 2012
237
18

Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases.
Nobuhisa Ishikawa, Noboru Hattori, Akihito Yokoyama, Nobuoki Kohno. Respir Investig 2012
166
18

Prognostic value of serial serum KL-6 measurements in patients with idiopathic pulmonary fibrosis.
Kentaro Wakamatsu, Nobuhiko Nagata, Hiroyuki Kumazoe, Keishi Oda, Hiroshi Ishimoto, Michihiro Yoshimi, Shohei Takata, Minako Hamada, Yoshifusa Koreeda, Kouji Takakura,[...]. Respir Investig 2017
45
18

Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis.
Antje Prasse, Corinna Probst, Elena Bargagli, Gernot Zissel, Galen B Toews, Kevin R Flaherty, Manfred Olschewski, Paola Rottoli, Joachim Müller-Quernheim. Am J Respir Crit Care Med 2009
206
18

TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
Justin M Oldham, Shwu-Fan Ma, Fernando J Martinez, Kevin J Anstrom, Ganesh Raghu, David A Schwartz, Eleanor Valenzi, Leah Witt, Cathryn Lee, Rekha Vij,[...]. Am J Respir Crit Care Med 2015
151
18

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
Anna L Peljto, Yingze Zhang, Tasha E Fingerlin, Shwu-Fan Ma, Joe G N Garcia, Thomas J Richards, Lori J Silveira, Kathleen O Lindell, Mark P Steele, James E Loyd,[...]. JAMA 2013
259
18

Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Imre Noth, Yingze Zhang, Shwu-Fan Ma, Carlos Flores, Mathew Barber, Yong Huang, Steven M Broderick, Michael S Wade, Pirro Hysi, Joseph Scuirba,[...]. Lancet Respir Med 2013
296
18

Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.
Nicoline M Korthagen, Coline H M van Moorsel, Nicole P Barlo, Henk J T Ruven, Adrian Kruit, Michiel Heron, Jules M M van den Bosch, Jan C Grutters. Respir Med 2011
76
18

Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.
Ganesh Raghu, Juergen Behr, Kevin K Brown, Jim J Egan, Steven M Kawut, Kevin R Flaherty, Fernando J Martinez, Steven D Nathan, Athol U Wells, Harold R Collard,[...]. Ann Intern Med 2013
272
18

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.
Toby M Maher, Eunice Oballa, Juliet K Simpson, Joanne Porte, Anthony Habgood, William A Fahy, Aiden Flynn, Philip L Molyneaux, Rebecca Braybrooke, Hrushikesh Divyateja,[...]. Lancet Respir Med 2017
82
18

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study.
R Gisli Jenkins, Juliet K Simpson, Gauri Saini, Jane H Bentley, Anne-Marie Russell, Rebecca Braybrooke, Philip L Molyneaux, Tricia M McKeever, Athol U Wells, Aiden Flynn,[...]. Lancet Respir Med 2015
166
18

Clinical significance of mTOR, ZEB1, ROCK1 expression in lung tissues of pulmonary fibrosis patients.
Jong Sun Park, Hyo Jin Park, Young Sik Park, Sang-Min Lee, Jae-Joon Yim, Chul-Gyu Yoo, Sung Koo Han, Young Whan Kim. BMC Pulm Med 2014
30
9

The lncRNA ZEB1-AS1 sponges miR-181a-5p to promote colorectal cancer cell proliferation by regulating Wnt/β-catenin signaling.
Shao-Yan Lv, Ti-Dong Shan, Xin-Ting Pan, Zi-Bin Tian, Xi-Shuang Liu, Fu-Guo Liu, Xue-Guo Sun, Hui-Guang Xue, Xin-Hua Li, Yue Han,[...]. Cell Cycle 2018
33
9

lncRNA PFAR Promotes Lung Fibroblast Activation and Fibrosis by Targeting miR-138 to Regulate the YAP1-Twist Axis.
Xiaoguang Zhao, Jian Sun, Yingzhun Chen, Wei Su, Huitong Shan, Yue Li, Yining Wang, Nan Zheng, Hongli Shan, Haihai Liang. Mol Ther 2018
42
9

miR-141 regulates TGF-β1-induced epithelial-mesenchymal transition through repression of HIPK2 expression in renal tubular epithelial cells.
Yuanhang Huang, Junrong Tong, Feng He, Xinpei Yu, Liming Fan, Jing Hu, Jiangping Tan, Zhengliang Chen. Int J Mol Med 2015
48
9

A novel lnc-PCF promotes the proliferation of TGF-β1-activated epithelial cells by targeting miR-344a-5p to regulate map3k11 in pulmonary fibrosis.
Huizhu Liu, Bingsi Wang, Jinjin Zhang, Songzi Zhang, Youlei Wang, Jie Zhang, Changjun Lv, Xiaodong Song. Cell Death Dis 2017
25
9

All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats.
Xiaodong Song, Weili Liu, Shuyang Xie, Meirong Wang, Guohong Cao, Cuiping Mao, Changjun Lv. Lab Invest 2013
45
9

Up-regulated miR-133a orchestrates epithelial-mesenchymal transition of airway epithelial cells.
Linjie Chen, Xiaobai He, Yan Xie, Yapei Huang, Dennis W Wolff, Peter W Abel, Yaping Tu. Sci Rep 2018
5
20

Ligand-independent transforming growth factor-β type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition.
Lucas DeMaio, Stephen T Buckley, Manda S Krishnaveni, Per Flodby, Mickael Dubourd, Agnes Banfalvi, Yiming Xing, Carsten Ehrhardt, Parviz Minoo, Beiyun Zhou,[...]. J Pathol 2012
35
9

Molecular mechanisms of epithelial-mesenchymal transition.
Samy Lamouille, Jian Xu, Rik Derynck. Nat Rev Mol Cell Biol 2014
9

lncRNA ZEB1-AS1 Was Suppressed by p53 for Renal Fibrosis in Diabetic Nephropathy.
Juan Wang, Jian Pan, Huiling Li, Jie Long, Fang Fang, Junxiang Chen, Xuejin Zhu, Xudong Xiang, Dongshan Zhang. Mol Ther Nucleic Acids 2018
37
9

ZEB1-AS1: A crucial cancer-related long non-coding RNA.
Jinglin Li, Zhenglong Li, Kaiming Leng, Yi Xu, Daolin Ji, Lining Huang, Yunfu Cui, Xingming Jiang. Cell Prolif 2018
39
9

HOTAIR promotes osteosarcoma development by sponging miR-217 and targeting ZEB1.
Bing Wang, Xing-Long Qu, Jiaxiang Liu, Junhui Lu, Zong-Yu Zhou. J Cell Physiol 2019
26
9

lncRNA PFAL promotes lung fibrosis through CTGF by competitively binding miR-18a.
Xuelian Li, Tong Yu, Huitong Shan, Hua Jiang, Jian Sun, Xiaoguang Zhao, Wei Su, Lida Yang, Hongli Shan, Haihai Liang. FASEB J 2018
28
9


The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
Philip A Gregory, Andrew G Bert, Emily L Paterson, Simon C Barry, Anna Tsykin, Gelareh Farshid, Mathew A Vadas, Yeesim Khew-Goodall, Gregory J Goodall. Nat Cell Biol 2008
9

ELF3 promotes epithelial-mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma.
Longbo Zheng, Ming Xu, Junjie Xu, Ke Wu, Qian Fang, Yuelong Liang, Senjun Zhou, Dong Cen, Lin Ji, Weili Han,[...]. Cell Death Dis 2018
52
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.